Business Context and Reporting Period
This Form 8-K was filed by Medtronic plc on February 12, 2015. The report discloses compensatory arrangements for certain officers, specifically the appointment of Bryan Hanson as Executive Vice President and President of the Covidien Business Group, and adjustments to the annual incentive plan targets for CEO Omar Ishrak and CFO Gary L. Ellis.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation details:
- Bryan Hanson (New Hire):
- Annual Base Salary: $750,000
- Target Annual Bonus: 85% of base salary
- Sign-on Equity (Options/RSUs): $3,000,000 target grant date value
- New Hire Bonus: $1,000,000
- Fiscal 2016 Long-Term Incentive Target: $2,700,000
- Omar Ishrak (CEO):
- New Target Annual Incentive (MIP): 175% of annual base salary (effective Q4 FY2015)
- Prior Target: 140% of annual base salary
- Gary L. Ellis (CFO):
- New Target Annual Incentive (MIP): 120% of annual base salary (effective Q4 FY2015)
- Prior Target: 90% of annual base salary
Material Changes Versus Prior Period
The primary material changes involve the increase in target incentive award levels for the CEO and CFO effective with the fourth quarter of fiscal year 2015. Additionally, the company has onboarded a new executive for the Covidien Business Group with a comprehensive compensation package including a $1 million new hire bonus and $3 million in initial equity grants.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of general business risks. It notes that Mr. Hanson will be subject to the company's stock ownership policies and retention requirements. Regarding contingencies, Mr. Hanson remains covered by the Covidien Change in Control Plan for two years following the consummation of the acquisition transactions (January 26, 2015), after which he will participate in Medtronic's standard severance plans.
Key Facts for Investor Verification
- Verify the total cash and equity cost of the Bryan Hanson appointment against the company's total executive compensation budget.
- Confirm the pro-rated calculation method for the increased MIP targets for Omar Ishrak and Gary L. Ellis for fiscal year 2015.
- Review the vesting criteria for the $3,000,000 sign-on equity grant to Mr. Hanson.
- Check the upcoming Form 10-Q for the quarter ended January 23, 2015, for the full text of the Letter Agreement.